Soumen Bhattacharyya: Clinical Implications and Risks in Metformin-Induced Vitamin B12 Deficiency
Soumen Bhattacharyya, College Teacher in the Department of Physiology at RBC College for Women, shared a post on LinkedIn:
“Metformin, Vitamin B12 Deficiency and Homocysteine: An Overlooked Clinical Link.
Metformin remains the cornerstone therapy for due to its efficacy, safety, and cardiovascular benefits.
However, an important long-term adverse effect often goes under-recognized: vitamin B12 deficiency and its metabolic consequences.
What’s the mechanism?
Metformin interferes with the calcium-dependent absorption of the intrinsic factor–vitamin B12 complex in the terminal ileum.
Additional contributing factors include altered gut motility and possible bacterial overgrowth.
Over time, this leads to reduced serum B12 levels.
Why does this matter?
Vitamin B12 plays a critical role in the conversion of homocysteine to methionine.
When B12 levels fall:
- Homocysteine accumulates
- Leads to a state of hyperhomocysteinemia
Clinical implications:
- Peripheral neuropathy (may mimic or worsen diabetic neuropathy)
- Megaloblastic anemia
- Increased cardiovascular risk associated with elevated homocysteine
What does the evidence say?
- Long-term metformin therapy is significantly associated with reduced B12 levels (de Jager et al., 2010)
- Reviews highlight impaired absorption as the primary mechanism (Niafar et al., 2021)
- Systematic analyses show increased homocysteine, particularly without vitamin supplementation (Aroda et al., 2016)
Clinical takeaway:
- Consider periodic monitoring of vitamin B12 in long-term metformin users
- Supplementation (oral or parenteral) when deficiency is detected
- Evaluate unexplained neuropathy carefully—don’t attribute everything to diabetes
Key References:
- de Jager J et al. Long-term treatment with metformin in patients with type 2 diabetes and risk of vitamin B-12 deficiency. BMJ, 2010.
- Niafar M et al. Long-term metformin therapy and vitamin B12 deficiency. (Review, PMC8311483)
- Aroda VR et al. Metformin and vitamin B12 deficiency: a systematic review.
A simple intervention—monitoring B12—can prevent significant morbidity in millions of patients on metformin.”

Stay updated with Hemostasis Today.
-
Jun 26, 2026, 18:28Daniel Pereira Monteiro: Why Is Beta Thalassaemia Major so Severe?
-
Jun 26, 2026, 18:27Pradip Pawar: Cell and Gene Therapy – Transforming Medicine in the 21st Century
-
Jun 26, 2026, 18:26Aviva Schwartz: How Can We Better Protect Patients After an Ischemic Stroke?
-
Jun 26, 2026, 18:25Does Reversing Factor Xa Inhibitors Really Carry as Much Thrombotic Risk as We Think? – RPTH Journal
-
Jun 26, 2026, 18:25Akshat Jain: Novel Therapies in Childhood Blood and Cancer Disorders
-
Jun 26, 2026, 16:57Abdul Muqtadir Abbasi: Anticoagulation in DVT Patients With Hidden Varices Requires Extreme Caution
-
Jun 26, 2026, 16:42Anesa Mulabecirovic: Why Von Willebrand Disease Takes Years to Diagnose in Women
-
Jun 26, 2026, 16:32Kaitlin Lichty: A New Identity Reflecting a Shared Legacy of Bleeding Disorders
-
Jun 26, 2026, 16:07Toong Youttananukorn: The WFH Registry Driving Better Care and Advocacy